Abstract
Advances in multiparametric magnetic resonance imaging (mpMRI) hold promise for the improved detection and characterization of prostate cancer. MpMRI combines diffusion-weighted imaging, dynamic contrast-enhanced sequences, or spectroscopy with conventional T2-weighted sequences. With a combination of anatomic and functional imaging sequences to identify suspicious regions in the prostate, pre-biopsy mpMRI has the potential to improve prostate cancer detection and risk stratification through MRI-targeted biopsy. In this chapter we review the role of mpMRI in prostate cancer detection, the outcomes of MRI-targeted biopsy, and the critical concepts currently under evaluation in validation of an MRI-based prostate cancer risk stratification strategy.
Original language | English (US) |
---|---|
Title of host publication | The Prostate Cancer Dilemma |
Subtitle of host publication | Selecting Patients for Active Surveillance, Focal Ablation and Definitive Therapy |
Publisher | Springer International Publishing |
Pages | 107-126 |
Number of pages | 20 |
ISBN (Electronic) | 9783319214856 |
ISBN (Print) | 9783319214849 |
DOIs | |
State | Published - Jan 1 2016 |
ASJC Scopus subject areas
- General Medicine